The Role of the Kynurenine Pathway in Microglia in Alzheimer's Disease

Principal Investigator
Daniel Zwilling, PhD
The J. David Gladstone Institutes
San Francisco, CA, USA
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$100,000
Active Dates
April 01, 2008 - March 31, 2010
Grant ID
A2008636
Mentor(s)
Paul Muchowski, PhD, J. David Gladstone Institutes
Goals
The major goal of this proposal is to use genetic and pharmacological approaches in mouse models of Alzheimer’s disease to characterize the contribution of the microglial kynurenine pathway to the pathogenesis of AD which may potentially contribute to the current understanding of pathogenesis of AD and provide new treatments.
Summary
Microglia are specialized brain cells that support the health and function of neurons. In response to brain injuries, these cells produce a large number of molecules that participate in inflammation and wound repair. While acute glial responses may help prevent neuronal damage, prolonged or aberrant activation of these cells may contribute to neurological disease. I am using genetic and pharmacological strategies to assess whether glial cells and their products contribute to cerebral amyloidosis and neurodegeneration in Alzheimer’s disease. Researchers have previously found that a certain microglial enzyme that is active in the metabolism of tryptophane (an amino acid) might be responsible for the production of neurotoxic substances. In AD patients this enzyme might be more active than usual. However, the inactivation of this enzyme by drugs might help to prevent the progression of AD pathology. The proposed experiments will increase our understanding of the role of microglia in Alzheimer’s disease and may also provide information critical for the preclinical development of drugs for Alzheimer’s disease.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD